GR
The Gabelli Healthcare & Wellness Trust
GRX · NYSE
$9.80 +0.82% (+$0.08)
1M -4.42%
Market Cap $144.8M
P/E Ratio 63.09x
Div. Yield 6.94%
ROE 1.42%
Bulios Fair Price
$9.84
0.4% upside
Current Price
$9.8
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GRX is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
43 /100
Fair P/S 9.48x
P/B 0.91x
P/E 63.09x
Growth
8 /100
Declining Book val. growth 8.16%
Rev. growth 0.68%
FCF growth N/A
Profitability
73 /100
Strong Op. margin 31.04%
Net margin 15.02%
FCF margin N/A
Quality
34 /100
Average ROA 0.95%
Asset turnover 0.06x
ROE 1.42%
Debt
0 /100
High Current ratio 0.03x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
28 /100
Unstable Rev. volatility 241.31%
EPS volatility 564.59%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GRX
Online
Sector
Financial Services
Industry
Asset Management
CEO
Wayne Christopher Pinsent
Employees
-
Headquarters
Rye